Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine plus midazolam versus remifentanil plus midazolam in neurosurgical pediatric patients
2006-003217-40Phase 3Terminated
- Sponsor
- Policlinico Gemelli
- Start
- Jan 2007
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in malignant neoplasm of nervous system comparing ketamine + midazolam with remifentanil + midazolam (2 arms). Primary endpoints: Cerebral hemodynamic safety of ketamine target-controlled infusion and Effect of increased ketamine plasma concentration on cerebral hemodynamics. Started Jan 2007; status: terminated.
02
Drugs
ketamineremifentanilmidazolam
03
Conditions
malignant neoplasm of nervous system
Beyond the preview
Go deeper on 2006-003217-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003217-40.